案例与白皮书2024-09-19
How Porton's Expertise Enhances Mutual Benefits in License In/Out Agreements
Porton's extensive expertise in technical transfer, supply chain optimization, and regulatory affairs (RA) knowledge significantly benefits both parties involved in license in and out scenarios. With Porton's proficiency in technical transfer, new technologies can be seamlessly integrated and implemented, ensuring increased production efficiency and superior product quality. Their strategies for supply chain optimization effectively reduce costs and enhance supply chain stability. Additiona
阅读全文
相关新闻
了解更多
案例与白皮书2024-11-06
通过氢化反应的高通量筛选和优化实现ENT-03的不对称合成
Trodusquemine 是具有重要生理活性的天然产物，ENT-03 被预测为是在哺乳动物体内具有和trodusquemine同等生理活性。我们制备了 ENT-03 的 C-25 异构体，并在小鼠大脑中检测到了这两种异构体。特罗杜司喹和 ENT-03 对肥胖症和胰岛素抵抗都有显著效果。ENT-03 被选中开发用于治疗糖尿病和肥胖症。
案例与白皮书2024-09-19
ADC药物中有效载荷控制策略与方法分析
抗体偶联药物（ADC）作为一种新型抗体药物，通过将靶向特异性抗原的抗体或抗体片段与有效载荷通过连接子偶联而成，兼具传统小分子药物的强效作用和抗体药物的靶向性。这种特性使得ADC药物能够更有选择性地将有效载荷递送至癌细胞、肿瘤微环境或其他靶细胞中，从而降低全身毒性。因此，ADC药物也在近年迎来了爆发式的增长黄金时代。
